LUCENTIS 0.23 mg

$1,600.00

Category:
  • Description

Description

Ranibizumab belongs to the class of medications called antivascular endothelial growth factors. It is used to treat “wet,” age-related macular degeneration, a condition where blood vessels behind the retina start to grow and leak blood and fluid. This causes damage to the macula (the centre of the retina) and results in central vision loss that can occur quickly.

Ranibizumab helps to slow down vision loss and may improve vision by stopping the growth and leakage of new blood vessels in the eye.

Ranibizumab is also used to treat decreased vision caused by fluid build-up in the eye as a result of complications of diabetes, blockage of the blood vessel leading away from the macula (retinal vein occlusion) and a condition called pathological myopia.

This medication may be available under multiple brand names and/or in several different forms. Any specific brand name of this medication may not be available in all of the forms or approved for all of the conditions discussed here. As well, some forms of this medication may not be used for all of the conditions discussed here.

Your doctor may have suggested this medication for conditions other than those listed in these drug information articles. If you have not discussed this with your doctor or are not sure why you are being given this medication, speak to your doctor. Do not stop receiving this medication without consulting your doctor.

Do not give this medication to anyone else, even if they have the same symptoms as you do. It can be harmful for people to use this medication if their doctor has not prescribed it.